drugset / Trial / NCT03505255

Comparison Between Intraperitoneal Versus Intramuscular Neostigmine on Pattern of Postoperative GIT Motility in Patients Undergoing Laparoscopic Cholecystectomy

NCT03505255

Phase 4 Unknown 160 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal in this work is to compare between the effects of intraperitoneal versus intramuscular neostigmine on pattern of postoperative GIT motility in patients undergoing laparoscopic cholecystectomy

Timeline

Start
2018-09-01
Primary completion
2020-09
Completion
2020-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.25 mg Intrathecal
Comparator Neostigmine Other / unclassified 0.5 mg Intrathecal

Indications

No indication recorded.